Individuals Stopping Slimming Medications Gain Back Pounds Far More Rapidly Compared to Dieters

New research indicates that individuals who stop using popular slimming jabs like Wegovy and Mounjaro can put back on reduced body mass at a significantly accelerated pace than those who stop traditional lifestyle regimens.

Research printed in a prominent health publication demonstrates that while obese individuals frequently drop about a fifth of their total mass while undergoing treatment, the weight comes back at an average rate of 0.8 kg per month after stopping.

"Individuals purchasing these medications must be informed of the risk of fast weight regain when the medication is stopped," cautioned expert Dr. Susan Jebb.

That rate of regain implies a return to pre-treatment weight in about a year and a half.

Weighing Approaches

The research, which looked at 37 of studies involving thousands of participants, compared the results of these new drugs with other pills.

Scientists point out that individuals who lose weight through dieting usually have a less rapid creep back—perhaps 100 grams monthly—after stopping.

Understanding the Rapid Rebound

Nutrition scientists propose the mode of action of the drugs accounts for the heightened weight return.

GLP-1 drugs copy a body's own chemical called GLP-1, which helps regulate appetite.

"Sustained high doses of the hormone concentrations far above than the body's typical production may cause the system to generate a reduced amount of its own natural GLP-1, and may also reduce sensitivity to its actions," said Dr. Adam Collins, a dietetics specialist.

"Discontinuation of this medication results in hunger is no longer kept in check, making overeating much more probable."

A Chronic Issue?

Medical guidelines suggest the injections for people with weight-linked health risks, accompanied by prescribed lifestyle changes.

Many experts say that, due to the significant potential of relapse, the treatment is often ongoing.

This opinion is echoed by pharmaceutical companies, who state that the findings "highlight the persistent nature of obesity," comparing it to managing conditions like hypertension.

Patient Accounts

Individuals who have stopped the jabs report a intense resurgence of hunger.

"I experienced something that goes on and I was suddenly ravenous," said a patient.

This difficulty is exacerbated if individuals have not developed permanent lifestyle or habit modifications during therapy.

Growing Adoption

Recent estimates show that a significant number of adults in the UK have tried weight-loss jabs in the past year, with demand remaining high.

• Use is greater among females compared to males.
• The 40s and 50s demographic shows the greatest level of interest.
• Many obtain the drugs through private healthcare rather than public health services.

Ultimately, experts caution that while the jabs are potent agents for weight loss, they are not a permanent cure and long-term success relies on ongoing behavioural changes.